The goal of the Education and Information Transfer Core (EITC) in the University of Pennsylvania Alzheimer's Disease Center (ADC) is to improve how healthcare professionals, patients and caregivers understand and practice the standard of care for the diagnosis and treatment of patients with Alzheimer's disease (AD) and other neurodegenerative dementias. To achieve this goal, the EITC provides education and training to: 1) patients and their families who attend the Memory Disorders Clinic; 2) nurse practitioners; physician assistants; and residents and fellows in family medicine, neurology, internal medicine, and geriatrics; and 3) Spanish speaking patients and their caregivers. The EITC will continue its existing successful education and outreach programs and also expand its mission and skills in the following ways: 1) continue to provide up-to-date in-clinic and internet resource centers, 2) continue to provide state of the art training to healthcare professionals, 3) continue to provide an educational and outreach program in the Latino community in a joint initiative with the Alzheimer's Association of Greater Philadelphia and the Core B Clinica Latina Para Trastornos de la Memoria satellite clinic, and 4) 4) develop and implement interventions that assist patients and caregivers in making challenging ethical decisions about treatment and research. Wherever possible, we will collaborate with the local chapter of the Alzheimer's Association and disseminate successful products to other National Institute on Aging (NIA) funded ADCs and the NIA's ADEAR program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG010124-11
Application #
6494704
Study Section
Project Start
1991-09-30
Project End
2006-06-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Gehrman, Philip; Gooneratne, Nalaka S; Brewster, Glenna S et al. (2018) Impact of Alzheimer disease patients' sleep disturbances on their caregivers. Geriatr Nurs 39:60-65
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Chen-Plotkin, Alice S (2018) Parkinson disease: Blood transcriptomics for Parkinson disease? Nat Rev Neurol 14:5-6
Irwin, David J; Hurtig, Howard I (2018) The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. J Alzheimers Dis Parkinsonism 8:
Henderson, Michael X; Peng, Chao; Trojanowski, John Q et al. (2018) LRRK2 activity does not dramatically alter ?-synuclein pathology in primary neurons. Acta Neuropathol Commun 6:45
Gibbons, Garrett S; Lee, Virginia M Y; Trojanowski, John Q (2018) Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review. JAMA Neurol :
Smith, Kara M; Ash, Sharon; Xie, Sharon X et al. (2018) Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease. J Speech Lang Hear Res 61:1691-1699
Nasrallah, Ilya M; Chen, Yin Jie; Hsieh, Meng-Kang et al. (2018) 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. J Nucl Med 59:299-306
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194

Showing the most recent 10 out of 720 publications